1. Home
  2. ADPT vs CNL Comparison

ADPT vs CNL Comparison

Compare ADPT & CNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • CNL
  • Stock Information
  • Founded
  • ADPT 2009
  • CNL 2018
  • Country
  • ADPT United States
  • CNL Canada
  • Employees
  • ADPT N/A
  • CNL N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • CNL
  • Sector
  • ADPT Health Care
  • CNL
  • Exchange
  • ADPT Nasdaq
  • CNL NYSE
  • Market Cap
  • ADPT 1.1B
  • CNL 871.3M
  • IPO Year
  • ADPT 2019
  • CNL N/A
  • Fundamental
  • Price
  • ADPT $9.03
  • CNL $10.18
  • Analyst Decision
  • ADPT Buy
  • CNL Strong Buy
  • Analyst Count
  • ADPT 6
  • CNL 1
  • Target Price
  • ADPT $9.83
  • CNL $8.00
  • AVG Volume (30 Days)
  • ADPT 3.0M
  • CNL 96.3K
  • Earning Date
  • ADPT 05-01-2025
  • CNL 01-01-0001
  • Dividend Yield
  • ADPT N/A
  • CNL N/A
  • EPS Growth
  • ADPT N/A
  • CNL N/A
  • EPS
  • ADPT N/A
  • CNL N/A
  • Revenue
  • ADPT $189,527,000.00
  • CNL N/A
  • Revenue This Year
  • ADPT $21.20
  • CNL N/A
  • Revenue Next Year
  • ADPT $21.99
  • CNL N/A
  • P/E Ratio
  • ADPT N/A
  • CNL N/A
  • Revenue Growth
  • ADPT 8.61
  • CNL N/A
  • 52 Week Low
  • ADPT $2.99
  • CNL $2.43
  • 52 Week High
  • ADPT $10.28
  • CNL $11.61
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.82
  • CNL N/A
  • Support Level
  • ADPT $8.38
  • CNL N/A
  • Resistance Level
  • ADPT $9.51
  • CNL N/A
  • Average True Range (ATR)
  • ADPT 0.66
  • CNL 0.00
  • MACD
  • ADPT 0.16
  • CNL 0.00
  • Stochastic Oscillator
  • ADPT 63.02
  • CNL 0.00

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About CNL COLLECTIVE MINING LTD

Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia. The company is rapidly advancing exploration on large-scale copper-gold-molybdenum porphyry targets in the mining-friendly department of Caldas in Colombia. Drilling is underway at the Guayabales project which is strategically located contiguous to the Marmato deposit, with initial assay results ongoing.

Share on Social Networks: